Factor xiii Intravenous and Lorcaserin Extended-Release Tablets
Determining the interaction of Factor xiii Intravenous and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: factor XIII
Brand name: Corifact, Tretten
Synonyms: Factor XIII, Factor XIII A-Subunit (Recombinant)
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Factor xiii Intravenous-Lorcaserin Hydrochloride
- Factor xiii Intravenous-Lorcaserin Tablets
- Factor xiii Intravenous-Lorcet
- Factor xiii Intravenous-Lorcet Plus
- Factor xiii Intravenous-Lorcet Tablets
- Factor xiii Intravenous-Lorlatinib
- Lorcaserin Extended-Release Tablets-Factrel
- Lorcaserin Extended-Release Tablets-FaLessa
- Lorcaserin Extended-Release Tablets-FaLessa Kit
- Lorcaserin Extended-Release Tablets-Fallback Solo
- Lorcaserin Extended-Release Tablets-Falmina
- Lorcaserin Extended-Release Tablets-Famciclovir